May 2026
📣 VC round data is live. Check it out!
Largest Accommodation Public Companies in Israel
Benchmark revenue and EBITDA valuation multiples for public comps like
Fattal Hotel Group, Isrotel, Alrov Group, Dan Hotels and Elbit Imaging.
 | Fattal Holdings (1998) Ltd is engaged in the maintenance, management, operation, and rental of hotels in Israel. Its geographical segment includes Israel; and Abroad, mainly Germany; the UK and Ireland, and others. The company generates maximum revenue from Abroad, mainly in Germany. | $261 | +52% | $4B | $12B | 4.5x | 13.5x | ||
| Isrotel Ltd manages & operates hotels which includes activities like restaurants, swimming pool halls, entertainment, and various recreation facilities. Its hotels include the Royal Beach (Eilat), the Isrotel King Solomon, & Isrotel Sport Club, among others. It operates more than fifteen hotels in Israel. | $52 | +88% | $3B | $4B | 4.8x | 17.0x | ||
| Alrov Properties & Lodgings Ltd is an Israel-based real estate company. It is involved in investing in, developing and operating luxury projects. The company operating segments include Investment Property, lodging overseas, Lodging in Israel, Securities and others. It generates maximum revenue from the Investment Property segment. The company initiates projects related to hotels, office buildings, commercial and residential properties. | $98 | +58% | $2B | $4B | 8.7x | 4.7x | ||
| Dan Hotels Ltd owns and operates hotel chain in Israel. The company's collection includes approximately 14 hotels. It also owns and manages VIP Lounges at Ben Gurion Airport. In addition it provides catering services to the Israeli defense forces. | $10 | +37% | $1B | $1B | 2.6x | 24.5x | ||
| Elbit Imaging Ltd is an Israel based company. The business activity of the group is operated through two segments including Medical industries and devices, and Plots in India. Geographically the business presence is in the region of America, Europe, and ROW. The company derives maximum revenue from the Medical industries and devices segment which operates in the field of life science that includes development, production, and marketing of treatment-oriented medical systems, and for certain cancer diseases in the America region. | $2 | -- | $21M | $54M | — | — | ||
| Median | $52 | +55% | $2B | $4B | 4.6x | 15.3x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.